Literature DB >> 8890950

The use of intermediate electron acceptors to enhance MTT bioreduction in a microculture tetrazolium assay for human growth hormone.

C J Goodwin1, S J Holt, S Downes, N J Marshall.   

Abstract

We contrast the effects of three intermediate electron acceptors (IEAs) on the highly quantitative ESTA bioassay for human growth hormone. This is a microculture tetrazolium assay based upon the in vitro reduction of the tetrazolium salt MTT, by Nb2 cells which have been activated with hGH. Each of the IEAs influenced MTT-formazan production in a distinctive manner. The two quinonoids, namely menadione and co-enzyme Q0 markedly increased the MTT-formazan produced by hormone activated Nb2 cells and thereby amplified the response of our bioassay for human growth hormone (hGH). The exceptionally low bioassay baseline which is characteristic of the unstimulated Nb2 cells when only MTT is added was retained in the presence of CoQ0, but was greatly increased by menadione. Phenazine methosulphate, which is the most widely used redox intermediary in microculture tetrazolium assays, also increased the baseline, but had only a minimal additional effect on MTT reduction by activated Nb2 cells. We conclude that CoQ0 is the preferred IEA for this ESTA bioassay for hGH.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8890950     DOI: 10.1016/s0024-3205(96)00512-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  1 in total

1.  Use of Ubp1 protease analog to produce recombinant human growth hormone in Escherichia coli.

Authors:  Anna Wojtowicz-Krawiec; Iwona Sokolowska; Maria Smorawinska; Luiza Chojnacka-Puchta; Diana Mikiewicz; Natalia Lukasiewicz; Alina Marciniak-Rusek; Renata Wolinowska; Anna Bierczynska-Krzysik; Anna Joanna Porebska; Jolanta Kuthan-Styczen; Lidia Gurba; Piotr Borowicz; Anna Mazurkiewicz; Grazyna Plucienniczak; Andrzej Plucienniczak
Journal:  Microb Cell Fact       Date:  2014-08-27       Impact factor: 5.328

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.